AzTrials
AzTrials

AccommodationNCT05684224

Assessing Dynamic Reading Behaviors Using Eye-Tracking Tobii Glasses

An observational study of Accommodation, run by State University of New York College of Optometry at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

HYPOTHESIS: 1. Horizontal convergence tracked with Tobii glasses is a reliable substitute for accommodation in young myopes and hyperopes with normal accommodative amplitudes 2. Young mypopes and hyperopes demonstrate different reading behaviors during near work AIMS \& OBJECTIVES: 1. Read more about this study

Who is it for?
Ages 18 to 30 years
Conditions the study is for
Accommodation
What is being tested?
Dynamic accommodation
How many people
10 participants
Where
1 siteUnited States
Study dates
14 Dec 2022to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Adult

Study population: Young adults between 18 and 30 years of age. Subjects will be recruited from students at SUNY College of Optometry.

Who may be able to join

  • Age: Subjects who are 18 to 30 years old
  • Refractive error: Subjects with myopia between -1.00 and -5.00 D in each eye (n = 5), or hyperopia between +2.00 and +5.00 D in each eye (n = 5), determined by spherical equivalent using dry manifest refraction and binocular balance
  • Astigmatism <= 0.75 D in each eye
  • Anisometropia <= 1.50 D
  • BCVA at distance 20/20 in each eye
  • Habitual contact lens wears or willing to wear single vision and multifocal contact lenses during the 2nd study visit
  • Normal eye posture and accommodation
  • Good general and ocular health

Who cannot join

  • Strabismus at distance or near
  • Amblyopia
  • Significant anisometropia (>1.50 D)

Trial locations and contacts

1 site in 1 country.

Xiaoying Zhu, OD, PhD, MD, MS, FAAO contact

2129385541

xzhu@sunyopt.edu

Robert McPeek, PhD contact

212-938-5762

rmcpeek@sunyopt.edu

United States1 site, 1 recruiting
  • Xiaoying Zhu

    New York, New York, 10036

    Xiaoying Zhu, OD, PhD, MD, MS, FAAO, 2129385541, xzhu@sunyopt.edu

    Robert McPeek, PhD, 212-938-5762, rmcpeek@sunyopt.edu

    Recruiting

Other trials in United States

About this study

HYPOTHESIS:

  1. Horizontal convergence tracked with Tobii glasses is a reliable substitute for accommodation in young myopes and hyperopes with normal accommodative amplitudes
  2. Young mypopes and hyperopes demonstrate different reading behaviors during near work
Read more

AIMS \& OBJECTIVES:

  1. Compare the accommodative responses measured with the Grand Seiko open-field autorefractor to those derived from the Tobii Glasses, when subjects wear (1) spectacle glasses, (2) single vision contact lenses (SVCLs), and (3) multifocal contact lenses (MFCLs).
  2. Investigate subjects' natural and dynamic accommodative behaviors and eye postures during reading using the Tobii Glasses.
  3. Compare the change in natural and dynamic accommodative behaviors and eye postures during reading between myopes and hyperopes using the Tobii Glasses.
Read the detailed description

Excessive axial elongation underlying myopia development and progression predisposes the eye to various sight-threatening complications including myopic maculopathy, retinal detachment, and glaucoma. The persistent and progressive nature of the myopic axial elongation results in the cumulative lifetime risk of developing irreversible low vision or blindness to increase exponentially with increasing myopia severity. With rapidly increasing worldwide prevalence, myopia has become a leading cause of visual impairment and blindness. Preventing myopia progression in childhood is therefore critical. Rapid increases in myopia prevalence in recent decades highlight the significant impact of environmental factors on myopia development and progression, as change in gene pools cannot account for the dramatic change. There is a growing body of evidence of the protective effect of increased time outdoors against myopia onset and progression. Increased time outdoors has also been shown to reduce the impact of parental myopia as a risk factor for childhood myopia. A school-based intervention study that encouraged Taiwanese primary school children to spend 120 minutes outdoors each day demonstrated less reduced visual acuity, a surrogate measure of myopia, highlighting the benefits of increased time outdoors on myopia. This has prompted initiatives worldwide to encourage children to spend more time outside. Another key risk factor for myopia is near work. A recent meta-analysis reported greater time on near work to be associated with higher odds of myopia. Greater near work in the form of reading and writing are thought to be the underlying causal link between education and myopia. Studies have found that children with higher academic performance or who attend more academically orientated classes or schools tend to be more myopic. Students using near work distances shorter than 30 cm and for periods greater than 30 minutes experienced greater myopia progression after only 6-months. Screen time, often considered a surrogate of near work, has also been associated to the increased prevalence of myopia. Despite recognition of these key environmental and behavioral risk factors for myopia, guidelines on appropriate risk management in children undergoing myopia control treatments are minimal due to lack of robust evidence.

Various optical and pharmacological interventions have been developed to prevent the progression of childhood myopia, including specially-designed spectacles, multifocal contact lenses, orthokeratology, and low concentration atropine eye drops. However, no treatment is 100% effective; 20% of myopic children on treatment progress as if they were not being treated, and more than 50% of treated children still demonstrate significant progression. Accurate quantification of the visual environment and behavior of myopic children and the impact on treatment efficacy will guide clinicians on risk management and improve responses to existing treatments for progressive myopia. Multifocal soft contact lens (MFCL) with central distance correction and a peripheral plus power profile is an effective treatment strategy for myopia control in children, with variable efficacies. One possible explanation is that children wearing these lenses under-accommodate at near which could reduce the lenses' treatment effect. It would be important to track the dynamic reading behaviors to better understand how accommodation and other binocular functions may change during reading. As of now, no portal devices can track dynamic accommodation. Tobii glasses are wearable eye trackers that accurately record horizontal and vertical vergences, pupil size, and reading distance over time. Investigator's pilot data shows that horizontal convergence can be used as a substitute for accommodation in subjects with normal accommodative amplitudes and eye posture. This study aims to compare the accuracy of accommodative measurements obtained with the Grand Seiko open-field autorefractor and the Tobii Glasses, when subjects wear (1) spectacle glasses, (2) single vision contact lenses (SVCLs), and (3) MFCLs. This study will also track the subject's natural reading behavior.

Conditions
Accommodation
Being tested
Dynamic accommodation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dynamic accommodationBehavioural

    Dynamic accommodation will be tracked using the Tobii Glasses

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Horizontal convergence

    Horizontal convergence will be tracked using the Tobii Glasses

    Measured: Horizontal convergence during reading will be measured using the Tobii Glasses continuously for 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2023
  2. Study start14 Dec 2022
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05684224
Sponsor's protocol ID
IRBNET.ORG 1921452
Status last verified
Mar 2024
First submitted
1 Jan 2023
Last updated
22 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Accommodation, run by State University of New York College of Optometry at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xiaoying Zhu, OD, PhD, MD, MS, FAAO (2129385541, xzhu@sunyopt.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Horizontal convergence (time frame: Horizontal convergence during reading will be measured using the Tobii Glasses continuously for 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in